Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Messages, Profile, Reports, Research, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 36)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
30-Nov-09 Freedonia Group Inc, The The Freedonia Group Freedonia Focus on Cancer Therapies 23 $500 View Abstract
23-Nov-09 Reuters Investment Profile N/A Sanofi-Aventis SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Nanotechnology & MEMS Industry Trends, Statistics & Analysis 2009 (Summary) 34 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Nanotechnology & MEMS Industry Market Research and Competitive Analysis 2009 447 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Sanofi-Aventis SA (SNY) Profile & Biotech Industry Trends Analysis 2010 43 $149 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract
Next 20

Brokerage Reports (Showing 1 to 2 of 2)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
3-Nov-09 Thomson StreetEvents N/A SNY - Event Transcript of Sanofi-Aventis conference call, Oct. 30, 2009 / 2:00pm ET 24 $75 View Abstract
3-Nov-09 Thomson StreetEvents N/A SNY - Event Brief of Sanofi-Aventis conference call, Oct. 30, 2009 / 2:00pm ET 23 $75 View Abstract

Independent Reports (Showing 1 to 10 of 34)

Release
Date Contributor Author Title Pages Price More Info
30-Nov-09 Freedonia Group Inc, The The Freedonia Group Freedonia Focus on Cancer Therapies 23 $500 View Abstract
23-Nov-09 Reuters Investment Profile N/A Sanofi-Aventis SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Nanotechnology & MEMS Industry Trends, Statistics & Analysis 2009 (Summary) 34 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Nanotechnology & MEMS Industry Market Research and Competitive Analysis 2009 447 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Sanofi-Aventis SA (SNY) Profile & Biotech Industry Trends Analysis 2010 43 $149 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.